v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING ACTIVITIES    
Net income including noncontrolling interest $ 436.6 $ 406.5
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 180.5 161.2
Amortization 82.6 74.9
Deferred income taxes 19.4 (21.0)
Share-based compensation expense 40.3 42.2
Pension and postretirement plan contributions (18.1) (15.6)
Pension and postretirement plan (income) expense, net 9.1 3.4
Restructuring charges, net of cash paid 3.5 21.8
Sale of global surgical solutions business   1.1
Other, net 10.6 (4.4)
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 13.5 (9.1)
Inventories (47.3) (69.1)
Other assets (117.2) (29.9)
Accounts payable 15.5 (2.5)
Other liabilities (183.1) (190.1)
Cash provided by operating activities 445.9 369.4
INVESTING ACTIVITIES    
Capital expenditures (348.5) (237.9)
Property and other assets sold 0.2 21.6
Divestiture of businesses, net of cash divested   (14.9)
Other, net (7.2) 7.2
Cash used for investing activities (355.5) (224.0)
FINANCING ACTIVITIES    
Net issuances of commercial paper and notes payable 201.6 4.5
Long-term debt borrowings 53.0  
Reacquired shares (344.4) (153.7)
Dividends paid (215.9) (192.0)
Exercise of employee stock options 83.5 98.5
Other, net (3.6) 1.1
Cash used for financing activities (225.8) (241.6)
Effect of exchange rate changes on cash and cash equivalents 9.0 2.0
Decrease in cash and cash equivalents (126.4) (94.2)
Cash and cash equivalents, beginning of period 646.2 1,256.8
Cash and cash equivalents, end of period $ 519.8 $ 1,162.6